Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
Accord Healthcare, Inc.

Accord Healthcare, Inc. Recalls

All product recalls associated with Accord Healthcare, Inc..

Get alerts for this brand

Recall Summary

Total Recalls

1000

Past Year

593

Class I (Serious)

Most Recent

Jan 2026

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 1841–1860 of 10391 recalls

Phenylephrine Injection (Accord) - Manufacturing Deviation (2023)

CGMP Deviations: recalling drug products following an FDA inspection.

Class IIModerate

FDAFeb 7, 2023Nationwide• Accord Healthcare, Inc.

Vigabatrin Oral Solution 500 mg (Accord Healthcare) – Manufacturing Deviation (2023)

CGMP Deviations: recalling drug products following an FDA inspection.

Class IIModerate

FDAFeb 7, 2023Nationwide• Accord Healthcare, Inc.

Daptomycin for Injection 500 mg (Accord Healthcare) – CGMP Deviation (2023)

CGMP Deviations: recalling drug products following an FDA inspection.

Class II

1...91 929394 95...520

Page 93 of 520Next

Moderate

FDAFeb 7, 2023Nationwide• Accord Healthcare, Inc.

Pravastatin Sodium Tablets 80 mg (Accord Healthcare) – Manufacturing Deviation (2023)

CGMP Deviations: recalling drug products following an FDA inspection.

Class IIModerate

FDAFeb 7, 2023Nationwide• Accord Healthcare, Inc.

Glycopyrrolate Injection 0.2mg/mL (Accord Healthcare) – CGMP Issues (2023)

CGMP Deviations: recalling drug products following an FDA inspection.

Class IIModerate

FDAFeb 7, 2023Nationwide• Accord Healthcare, Inc.

Finasteride Tablets 5 mg (Accord Healthcare) – Manufacturing Deviation (2023)

CGMP Deviations: recalling drug products following an FDA inspection.

Class IIModerate

FDAFeb 7, 2023Nationwide• Accord Healthcare, Inc.

Montelukast Sodium Tablets (Accord) - Manufacturing Deviation (2023)

CGMP Deviations: recalling drug products following an FDA inspection.

Class IIModerate

FDAFeb 7, 2023Nationwide• Accord Healthcare, Inc.

Dofetilide Capsules 250 mcg (Accord Healthcare) – Manufacturing Deviation (2023)

CGMP Deviations: recalling drug products following an FDA inspection.

Class IIModerate

FDAFeb 7, 2023Nationwide• Accord Healthcare, Inc.

rOPINIRole Tablets 0.5 mg (Accord Healthcare) – CGMP Deviation (2023)

CGMP Deviations: recalling drug products following an FDA inspection.

Class IIModerate

FDAFeb 7, 2023Nationwide• Accord Healthcare, Inc.

Pirfenidone Tablets (Accord) - Manufacturing Deviation (2023)

CGMP Deviations: recalling drug products following an FDA inspection.

Class IIModerate

FDAFeb 7, 2023Nationwide• Accord Healthcare, Inc.

Pravastatin Sodium Tablets 10 mg (Accord Healthcare) – Manufacturing Deviation (2023)

CGMP Deviations: recalling drug products following an FDA inspection.

Class IIModerate

FDAFeb 7, 2023Nationwide• Accord Healthcare, Inc.

Atorvastatin Calcium Tablets (Accord) - Manufacturing Deviation (2023)

CGMP Deviations: recalling drug products following an FDA inspection.

Class IIModerate

FDAFeb 7, 2023Nationwide• Accord Healthcare, Inc.

Doxazosin Tablets 1mg (Accord Healthcare) – CGMP Issues (2023)

CGMP Deviations: recalling drug products following an FDA inspection.

Class IIModerate

FDAFeb 7, 2023Nationwide• Accord Healthcare, Inc.

Aripiprazole Tablets (Accord) - Manufacturing Deviation (2023)

CGMP Deviations: recalling drug products following an FDA inspection.

Class IIModerate

FDAFeb 7, 2023Nationwide• Accord Healthcare, Inc.

Simvastatin Tablets 80 mg (Accord Healthcare) – Manufacturing Deviation (2023)

CGMP Deviations: recalling drug products following an FDA inspection.

Class IIModerate

FDAFeb 7, 2023Nationwide• Accord Healthcare, Inc.

Glimepiride Tablets 4mg (Accord Healthcare) – CGMP Issues (2023)

CGMP Deviations: recalling drug products following an FDA inspection.

Class IIModerate

FDAFeb 7, 2023Nationwide• Accord Healthcare, Inc.

Finasteride Tablets (Accord) - Manufacturing Deviation (2023)

CGMP Deviations: recalling drug products following an FDA inspection.

Class IIModerate

FDAFeb 7, 2023Nationwide• Accord Healthcare, Inc.

Ropinirole Tablets (Accord) - Manufacturing Deviation (2023)

CGMP Deviations: recalling drug products following an FDA inspection.

Class IIModerate

FDAFeb 7, 2023Nationwide• Accord Healthcare, Inc.

Atorvastatin Calcium Tablets 20mg (Accord Healthcare) – CGMP Issues (2023)

CGMP Deviations: recalling drug products following an FDA inspection.

Class IIModerate

FDAFeb 7, 2023Nationwide• Accord Healthcare, Inc.

Rosuvastatin Tablets 20 mg (Accord Healthcare) – Manufacturing Deviation (2023)

CGMP Deviations: recalling drug products following an FDA inspection.

Class IIModerate

FDAFeb 7, 2023Nationwide• Accord Healthcare, Inc.